Clinical trials
Completed Neuralgia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
522 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 7 |
| 2003 | 8 |
| 2004 | 7 |
| 2005 | 14 |
| 2006 | 23 |
| 2007 | 20 |
| 2008 | 19 |
| 2009 | 17 |
| 2010 | 25 |
| 2011 | 32 |
| 2012 | 24 |
| 2013 | 20 |
| 2014 | 25 |
| 2015 | 17 |
| 2016 | 27 |
| 2017 | 23 |
| 2018 | 29 |
| 2019 | 26 |
| 2020 | 22 |
| 2021 | 26 |
| 2022 | 37 |
| 2023 | 27 |
| 2024 | 19 |
| 2025 | 13 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 522 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 20 |
| University Hospital, Clermont-Ferrand | 11 |
| Rigshospitalet, Denmark | 10 |
| Danish Pain Research Center | 9 |
| GlaxoSmithKline | 8 |
| NeurogesX | 8 |
| University of Sao Paulo | 8 |
| Barts & The London NHS Trust | 5 |
| Grünenthal GmbH | 5 |
| University of British Columbia | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuralgia | 522 |
| Pain | 96 |
| Chronic Pain | 77 |
| Neuralgia, Postherpetic | 36 |
| Spinal Cord Injuries | 35 |
| Diabetic Neuropathies | 33 |
| Postoperative Pain | 26 |
| Peripheral Nervous System Diseases | 24 |
| Low Back Pain | 22 |
| Diabetes Mellitus | 20 |
Trials
Showing 26 to 50 of 522. Each trial links to its page on Pharma Observatory.
422 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.